Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Invesque ( (TSE:IVQ) ) has issued an update.
Invesque Inc. has fully redeemed its US$27.3 million 9.75% unsecured subordinated debentures due December 30, 2027, with the securities retired on January 23, 2026 and subsequently delisted from the Toronto Stock Exchange. The move streamlines Invesque’s capital structure and reduces its reliance on high-cost subordinated debt, a step that may improve its financial flexibility and risk profile as it continues to focus on expanding and managing its portfolio of seniors housing real estate across North America.
The most recent analyst rating on (TSE:IVQ) stock is a Hold with a C$0.13 price target. To see the full list of analyst forecasts on Invesque stock, see the TSE:IVQ Stock Forecast page.
Spark’s Take on TSE:IVQ Stock
According to Spark, TipRanks’ AI Analyst, TSE:IVQ is a Neutral.
The score is held back primarily by weak financial performance (declining revenue, persistent losses, and high leverage with negative cash flows). Technical indicators provide partial offset with a clear short-term uptrend and positive momentum, while valuation remains difficult to support due to negative earnings and no stated dividend yield.
To see Spark’s full report on TSE:IVQ stock, click here.
More about Invesque
Invesque Inc. is a North American health care real estate company focused on capitalizing on aging demographics by investing in income-generating, private pay seniors housing communities. Its portfolio spans independent living, assisted living and memory care properties, operated through joint ventures with industry-leading partners as well as owner-occupied seniors housing assets where Invesque owns both the real estate and licensed operations.
YTD Price Performance: -13.33%
Average Trading Volume: 51,134
Technical Sentiment Signal: Sell
Current Market Cap: C$118.8M
See more insights into IVQ stock on TipRanks’ Stock Analysis page.

